Park et al. found that HS-173 improves radiotherapy by attenuating DNA damage response mediated by the ataxia-telangiectasia mutated (ATM) and DNA-dependent protein kinase catalytic subunit (DNA-PKcs) in pancreatic cancer cells [73]. The gene discussed is PRKDC; the disease is pancreatic neoplasm.